Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer

Open access
Glöckner, Sabine C., Dhir, Mashaal, Yi, Joo Mi, McGarvey, Kelly E., Van Neste, Leander, Louwagie, Joost, Chan, Timothy A., Kleeberger, Wolfram, de Bruïne, Adriaan P., Smits, Kim M., Khalid-de Bakker, Carolina A.J., Jonkers, Daisy M.A.E., Stockbrügger, Reinhold W., Meijer, Gerrit A., Oort, Frank A., Iacobuzio-Donahue, Christine, Bierau, Katja, Herman, James G., Baylin, Stephen B., Van Engeland, Manon, Schuebel, Kornel E., Ahuja, Nita·2009·Cancer Research

Abstract

We have used a gene expression array–based strategy to identify the methylation of tissue factor pathway inhibitor 2 (TFPI2), a potential tumor suppressor gene, as a frequent event in human colorectal cancers (CRC). TFPI2 belongs to the recently described group of embryonic cell Polycomb group (PcG)–marked genes that may be predisposed to aberrant DNA methylation in early stages of colorectal carcinogenesis. Aberrant methylation of TFPI2 was detected in almost all CRC adenomas (97%, n = 56) and stages I to IV CRCs (99%, n = 115). We further explored the potential of TFPI2 as a biomarker for the early detection of CRC using stool DNA–based assays in patients with nonmetastatic CRC and average-risk noncancer controls who were candidates for screening. TFPI2 methylation was detected in stool DNA from stage I to III CRC patients with a sensitivity of 76% to 89% and a specificity of 79% to 93%. Detection of TFPI2 methylation in stool DNA may act as a useful adjunct to the noninvasive strategies for screening of CRCs in the future. [Cancer Res 2009;69(11):4691–9]

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-0142

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 230

Metadata

Authors
Glöckner, S. C., Dhir, M., Yi, J. M., McGarvey, K. E., Van Neste, L., Louwagie, J., Chan, T. A., Kleeberger, W., de Bruïne, A. P., Smits, K. M., Khalid-de Bakker, C. A. J., Jonkers, D. M. A. E., Stockbrügger, R. W., Meijer, G. A., Oort, F. A., Iacobuzio-Donahue, C., Bierau, K., Herman, J. G., Baylin, S. B., Van Engeland, M., Schuebel, K. E., & Ahuja, N.
Venue
Cancer Research
Published
2009-06-01
Volume
69
Issue
11
Pages
4691-4699
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2111853146
Cited by
230
References
6
FWCI
7.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-0142
The paper
Glöckner, S. C., Dhir, M., Yi, J. M., McGarvey, K. E., Van Neste, L., Louwagie, J., Chan, T. A., Kleeberger, W., de Bruïne, A. P., Smits, K. M., Khalid-de Bakker, C. A. J., Jonkers, D. M. A. E., Stockbrügger, R. W., Meijer, G. A., Oort, F. A., Iacobuzio-Donahue, C., Bierau, K., Herman, J. G., Baylin, S. B., . . . Ahuja, N. (2009). Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-0142

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.